Gba Mutations | List of Frontiers open access articles

Review

Published on 23 Mar 2022

Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications

in Parkinson’s Disease and Aging-related Movement Disorders

Wei Zheng
Dongsheng Fan

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.851135

11,934 views
19 citations

Review

Published on 27 Apr 2012

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies

in Ageing

Maria Rosario Almeida

Frontiers in Neurology

doi 10.3389/fneur.2012.00065

9,696 views
15 citations

Study Protocol

Published on 26 May 2023

The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial

in Alzheimer's Disease and Related Dementias

Luiza Jadwiga Chwiszczuk
Monica Haraldseid Breitve
Bjørn-Eivind Bordewick Kirsebom
Per Selnes
John Chr. Fløvig
Anne-Brita Knapskog
Ragnhild E. Skogseth
Jessica Hubbers
Elin Holst-Larsen
Arvid Rongve

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1163184

10,321 views
16 citations

Original Research

Published on 15 Mar 2022

Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control

in Autonomic Neuroscience

Angelica Carandina
Giulia Lazzeri
Gabriel Dias Rodrigues
Giulia Franco
Edoardo Monfrini
Federica Arienti
Emanuele Frattini
Ilaria Trezzi
Pedro Paulo da Silva Soares
Chiara Bellocchi

Frontiers in Neuroscience

doi 10.3389/fnins.2022.842498

5,840 views
18 citations

Original Research

Published on 19 Aug 2025

Comparative study of autonomic dysfunction between Parkinson’s disease with LRRK2, PRKN, and GBA mutations

in Autonomic Disorders

Bárbara Maldotti Dalla Corte
Nayron Medeiros Soares
Eurípedes Gomes de Carvalho Neto
Carlos Roberto de Mello Rieder

Frontiers in Neurology

doi 10.3389/fneur.2025.1657824

2,115 views
1 citation

Original Research

Published on 30 Jun 2020

Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland

in Neurogenetics

Diana A. Olszewska
Allan McCarthy
Alexandra I. Soto-Beasley
Ronald L. Walton
Brian Magennis
Russell L. McLaughlin
Orla Hardiman
Owen A. Ross
Tim Lynch

Frontiers in Neurology

doi 10.3389/fneur.2020.00527

7,512 views
22 citations

Original Research

Published on 21 May 2019

Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease

in Movement Disorders

Tal Kozlovski
Alexis Mitelpunkt
Avner Thaler
Tanya Gurevich
Avi Orr-Urtreger
Mali Gana-Weisz
Netta Shachar
Tal Galili
Mira Marcus-Kalish
Susan Bressman

Frontiers in Neurology

doi 10.3389/fneur.2019.00531

4,992 views
23 citations

Perspective

Published on 10 Nov 2023

Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson’s disease and monogenic dystonia: a multidisciplinary team perspective

in Translational Neuroscience

Valentino Rački
Mario Hero
Eliša Papić
Gloria Rožmarić
Nada Starčević Čizmarević
Darko Chudy
Borut Peterlin
Vladimira Vuletić

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1282267

3,724 views
4 citations

Original Research

Published on 01 May 2024

Peripheral cutaneous synucleinopathy characteristics in genetic Parkinson’s disease

in Movement Disorders

Yanpeng Yuan
Yangyang Wang
Minglei Liu
Haiyang Luo
Xiaojing Liu
Lanjun Li
Chengyuan Mao
Ting Yang
Shuo Li
Xiaoyun Zhang

Frontiers in Neurology

doi 10.3389/fneur.2024.1404492

4,283 views
7 citations

Systematic Review

Published on 14 Nov 2025

Effects of glucocerebrosidase gene variations on the risk of Parkinson’s disease dementia: a meta-analysis

in Parkinson’s Disease and Aging-related Movement Disorders

Qiujie Li
Zhumei Bi
Weiming Liang
Shan Yin
Huaicheng Li
Zhongyou Liang
Minyao Wu
Jieru Quan
Cheng Li

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1671760

1,507 views

Articles

Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies

The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial

Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control

Comparative study of autonomic dysfunction between Parkinson’s disease with LRRK2, PRKN, and GBA mutations

Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland

Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease

Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson’s disease and monogenic dystonia: a multidisciplinary team perspective

Peripheral cutaneous synucleinopathy characteristics in genetic Parkinson’s disease

Effects of glucocerebrosidase gene variations on the risk of Parkinson’s disease dementia: a meta-analysis